EVENT
Operation Warp Speed
The 2020 US federal program that channeled $18 billion in public funding to COVID-19 vaccine development — and whose structural arrangement embodied the public-risk-private-reward pattern at maximum visibility.
Operation Warp Speed was the 2020 US federal program that channeled approximately $18 billion in public funding to accelerate COVID-19 vaccine development, manufacturing, and distribution. The program provided Moderna with nearly a billion dollars in development funding and Pfizer with a two-billion-dollar advance purchase commitment. It funded clinical trial infrastructure, manufacturing capacity, and distribution logistics. The structural arrangement — public capital bearing the commercial risk while private companies retained the intellectual property and commercial returns — represented the public-risk-private-reward pattern at its most visible. The program succeeded on its immediate objective: vaccines were developed, tested, and distributed at unprecedented speed. Mazzucato's framework identifies what the program did not do: establish any mechanism for the public investor to participate in the extraordinary commercial returns the investment enabled.
In The You On AI Field Guide
The program's structure followed conventional pharmaceutical procurement logic: the government paid for research and committed to purchase vaccine doses, in exchange for eventual delivery of vaccines. The intellectual property remained with the private firms. The